Income Statement

v3.10.0.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
REVENUES        
Real property rental $ 278,872 $ 222,254 $ 575,495 $ 222,254
Medical related consulting services - related parties 141,996 152,497 141,996 218,783
Development services and sales of developed products 75,225 86,515
Total Revenues 496,093 374,751 804,006 441,037
COSTS AND EXPENSES        
Real property operating expenses 195,941 161,854 406,215 161,854
Medical related consulting services - related parties 124,715 125,231 124,715 224,812
Development services and sales of developed products 42,093 58,613
Total Costs and Expenses 362,749 287,085 589,543 386,666
REAL PROPERTY OPERATING INCOME 82,931 60,400 169,280 60,400
GROSS PROFIT (LOSS) FROM MEDICAL RELATED CONSULTING SERVICES 17,281 27,266 17,281 (6,029)
GROSS PROFIT FROM DEVELOPMENT SERVICES AND SALES OF DEVELOPED PRODUCTS 33,132 27,902
OTHER OPERATING EXPENSES:        
Selling expense 6,279 14,990
Compensation and related benefits 487,452 205,473 1,026,266 388,400
Professional fees 593,025 172,705 1,164,797 379,923
Other general and administrative 266,121 91,927 551,373 152,659
Total Other Operating Expenses 1,346,598 476,384 2,742,436 935,972
LOSS FROM OPERATIONS (1,213,254) (388,718) (2,527,973) (881,601)
OTHER INCOME (EXPENSE)        
Interest income 1,300 210 1,708 1,004
Interest expense (24,932) (42,000) (261,918) (42,000)
Foreign currency transaction loss (106,929) (106,929) (57,244)
Other income 328
Total Other Expense, net (130,561) (41,790) (366,811) (98,240)
LOSS BEFORE INCOME TAXES (1,343,815) (430,508) (2,894,784) (979,841)
INCOME TAXES
NET LOSS (1,343,815) (430,508) (2,894,784) (979,841) [1]
LESS: NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST (49,421) (118,811)
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS (1,294,394) (430,508) (2,775,973) (979,841)
COMPREHENSIVE LOSS        
NET LOSS (1,343,815) (430,508) (2,894,784) (979,841)
Unrealized foreign currency translation (loss) gain (96,207) 7,647 (43,369) (32,124)
COMPREHENSIVE LOSS (1,440,022) (422,861) (2,938,153) (1,011,965)
LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST (49,540) (118,770)
COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (1,390,482) $ (422,861) $ (2,819,383) $ (1,011,965)
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS        
Basic and diluted $ (0.02) $ (0.01) $ (0.04) $ (0.02)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic and diluted 71,979,678 64,628,622 71,122,536 63,617,572
[1] The Company does not allocate any general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.

Source